Table 5.
Summary of adherence and adverse events (AEs).
| Variable | Placebo | FNZG | SIG | Total |
|---|---|---|---|---|
| Adherence no. (%) | ||||
| Day 1 | 30 (100) | 60 (100) | 59 (98) | 149 (99) |
| Day 7 | 30 (100) | 56 (93) | 58 (97) | 144 (96) |
| All AEs* | ||||
| Patch site reaction | 0 (0) | 4 (7) | 4 (7) | 8 (5) |
| Leading to study withdrawal | 0 (0) | 1 (2) | 0 (0) | 1 (1) |
| Resulting in hospitalization and death | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Values are the number (percentage). *Based on 149 patients (60 FNZG, 59 SJG, 30 placebo).